¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy.
Katz
Leah
L
Tulane University School of Medicine, New Orleans, LA 70130, USA. leahkatz85@gmail.com
Choueiri
Toni K
TK
Bellmunt
Joaquim
J
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D002250:Carbon Radioisotopes; D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008715:Methionine; D049268:Positron-Emission Tomography / Q000379:methods*; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D007211:Indoles; D011758:Pyrroles; D008715:Methionine; D000077210:Sunitinib